Madden Securities’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,000
| Closed | -$2.14M | – | 94 |
|
|
2023
Q2 | $2.14M | Sell |
21,000
-2,708
| -11% | -$276K | 1.1% | 29 |
|
|
2023
Q1 | $2.16M | Hold |
23,708
| – | – | 1.14% | 28 |
|
|
2022
Q4 | $901K | Hold |
23,708
| – | – | 0.47% | 46 |
|
|
2022
Q3 | $596K | Sell |
23,708
-60
| -0.3% | -$1.51K | 0.36% | 57 |
|
|
2022
Q2 | $722K | Hold |
23,768
| – | – | 0.4% | 56 |
|
|
2022
Q1 | $779K | Sell |
23,768
-15,544
| -40% | -$509K | 0.35% | 58 |
|
|
2021
Q4 | $1.04M | Buy |
39,312
+6,185
| +19% | +$163K | 0.49% | 56 |
|
|
2021
Q3 | $3.33M | Sell |
33,127
-1,675
| -5% | -$169K | 1.8% | 18 |
|
|
2021
Q2 | $4.93M | Buy |
34,802
+15
| +0% | +$2.12K | 2.57% | 6 |
|
|
2021
Q1 | $3.47M | Sell |
34,787
-365
| -1% | -$36.4K | 2.03% | 12 |
|
|
2020
Q4 | $4.35M | Sell |
35,152
-8,775
| -20% | -$1.08M | 2.8% | 5 |
|
|
2020
Q3 | $4.28M | Buy |
43,927
+575
| +1% | +$56K | 3.18% | 4 |
|
|
2020
Q2 | $6.76M | Buy |
+43,352
| New | +$6.76M | 6.02% | 2 |
|
|
2019
Q4 | $8.83M | Buy |
+43,199
| New | +$8.83M | 8.86% | 1 |
|